Engineering periplasmic ligand binding proteins as glucose nanosensors

Area of Science:

• Biotechnology
• Biomedical Engineering
• Analytical Chemistry

Background:

• Diabetes mellitus affects over 100 million individuals globally, necessitating enhanced blood glucose monitoring for effective disease management.
• Current monitoring methods have limitations, driving the need for innovative solutions like nanosensors.
• Periplasmic ligand-binding proteins have been previously engineered into glucose nanosensors.

Purpose of the Study:

• To review recent advancements in engineering periplasmic ligand-binding proteins for glucose nanosensors.
• To highlight developments in protein responsiveness, reporter groups, and robustness for improved sensor performance.
• To outline the essential characteristics for an implantable glucose nanosensor for diabetes management.

Main Methods:

• Summarizing recent literature on the modification of periplasmic ligand-binding proteins.
• Analyzing engineered proteins for responsiveness within the physiological blood glucose range.
• Evaluating the incorporation of novel reporter groups and enhancements in protein robustness.

Main Results:

• New versions of periplasmic ligand-binding proteins demonstrate improved responsiveness to glucose within the physiological range.
• Innovations include the use of novel reporter groups for enhanced signal detection.
• Engineered proteins exhibit increased robustness, a critical factor for sensor longevity and reliability.

Conclusions:

• Recent developments represent significant progress towards creating effective glucose nanosensors.
• Further protein engineering is essential to achieve the specificity, sensitivity, rapid response, reproducibility, and robustness required for implantable glucose nanosensors.
• These advancements are vital steps in developing next-generation tools for diabetes management.